Trial Profile
Single centre, retrospective study to evaluate the effect of transitioning patients with pulmonary arterial hypertension from intravenous prostacyclin to oral prostacyclin
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Mar 2016
Price :
$35
*
At a glance
- Drugs Treprostinil (Primary)
- Indications Pulmonary arterial hypertension
- Focus Therapeutic Use
- 07 Mar 2016 New trial record